 Inovio Pharmaceuticals Inc. NASDAQ: INO shares are trading higher Tuesday after the FDA removed a hold on the companys late-stage COVID-19 vaccine trial in the U.S. Inovio Pharmaceuticals is trading up 4.60 at 7.05 at market close Tuesday. 